CN107019724A - A kind of red sage compound tea with hypotensive activity - Google Patents
A kind of red sage compound tea with hypotensive activity Download PDFInfo
- Publication number
- CN107019724A CN107019724A CN201710256362.0A CN201710256362A CN107019724A CN 107019724 A CN107019724 A CN 107019724A CN 201710256362 A CN201710256362 A CN 201710256362A CN 107019724 A CN107019724 A CN 107019724A
- Authority
- CN
- China
- Prior art keywords
- parts
- red sage
- temperature
- taken
- moisture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of red sage compound tea with hypotensive activity.The tea is prepared from by the raw material of following weight：30 50 parts of red sage root leaf, 5 20 parts of ginkgo leaf, 2 10 parts of folium artemisiae argyi, 18 parts of honeysuckle, 15 parts of the sophora bud, 15 parts of the sterculia seed；The tea is made to produce synergistic function between raw medicinal material, is improved the blood pressure lowering effect of tea, improve mouthfeel, its drug effect is gentle, has no toxic side effect by the compatibility of optimizing raw material, is adapted to all Hypertensive Populations and is drunk for a long time.
Description
Technical field
The present invention relates to field of health-care beverage, more particularly to a kind of red sage compound tea with hypotensive activity.
Background technology
Tea-drinking is the eating habit of Chinese traditional, as people's living standard is improved, and new want is proposed to drinking tea
Ask, functional beverage continuously emerges, people will have tea and are combined together with prevention and health care, reach the dual effect drunk tea with health care
Really.And continuous exploration that Chinese medicine was also the Chinese nation by thousands of years and the national rarity of accumulation, it is slow in prevention and treatment
Property disease on have special effect, especially with continuing to increase for Chinese population aging, constantly change in living environment, life style
Today of change, the incidence of disease of various chronic diseases is also greatly improved.Although as the raising of medical technology, various diseases are controlled
Treatment method is also on the increase, and therapeutic effect is also being lifted steadily, but progress is little in the prevention and treatment of chronic disease, and in
Medicine but has the curative effect of uniqueness and effect, therefore, people that teabag drink is made in Chinese medicine and is drunk daily on the field, that is, meets people
Eating habit, the effect of prevention and treatment chronic disease can be played again, Chinese medicine teabag drink enjoys the favor of people.
Hypertension is the disease of lasting hyperpiesia, can cause the diseases such as apoplexy, heart disease, hemangioma, kidney failure, with dynamic
Pulse pressure rise is characterized, can be with heart, blood vessel, brain and kidney and other organs feature or the systemic disease of organic change.
The Chinese medicine species with hypotensive is various at present, but most of Chinese medicines are not appropriate for that teabag drink and then long-term drink is made
With, therefore, the Chinese medicine for lowering blood pressure material that minority can for a long time be drunk as teabag drink makes and has been known as health protection tea,
With certain blood pressure lowering effect.However, to there is blood pressure lowering effect all the time poor for the teabag drink that single medicinal material material is made, poor taste
Defect, accordingly, it would be desirable to further improve.
The content of the invention
It is an object of the invention to overcome the blood pressure lowering effect in the presence of existing antihypertensive healthcare teabag drink poor, poor taste
Not enough there is provided a kind of red sage compound tea with hypotensive activity.The tea makes bulk drug by the compatibility of optimizing raw material
Synergistic function is produced between material, the blood pressure lowering effect of tea is improved, improves mouthfeel, its drug effect is gentle, nontoxic pair
Effect, is adapted to all Hypertensive Populations and drinks for a long time.
In order to realize foregoing invention purpose, the invention provides a kind of red sage compound tea with hypotensive activity, this is answered
Square tea is prepared from by the raw material of following weight：30-50 parts of red sage root leaf, 5-20 parts of ginkgo leaf, 2-10 parts of folium artemisiae argyi,
1-8 parts of honeysuckle, 1-5 parts of the sophora bud, 1-5 parts of the sterculia seed.
Above-mentioned a kind of red sage compound tea with hypotensive activity, wherein described red sage root leaf, is the labiate red sage root
Leaf；The red sage root also known as red ginseng, radix salviae miltiorrhizae, red root etc.；It is inducing meastruation to relieve menalgia with promoting blood circulation, relieving restlessness that clears away heart-fire, the work(of cool blood to disappear carbuncle
Effect；For chest impediment and cardialgia, gastral cavity abdomen hypochondriac pain, lump in the abdomen lump in the abdomen accumulation, hot numbness pain, dysphoria and insomnia, irregular menstruation, dysmenorrhoea Amenorrhea, sore swells
Bitterly.
Wherein described ginkgo leaf, is Ginkgoaceae, the leaf of Ginkgo deciduous tree ginkgo；It is sweet, bitter, puckery；It is mild-natured；Return
The heart, lung channel；With astringing the lung, relieving asthma, promoting blood circulation and removing blood stasis, effect of analgesic.For treating deficiency syndrome of the lung cough and asthma；Coronary heart disease, angina pectoris, high blood
The diseases such as fat.
Wherein described folium artemisiae argyi, i.e. wormwood；It is bitter, pungent；It is warm-natured；Enter spleen, liver, kidney；With Wen Jing, dry, cold dispelling, only
Blood, anti-inflammatory, relieving asthma, cough-relieving, the effect such as antiabortive, antiallergy.
Wherein described honeysuckle, it is sweet, slight bitter, delicate fragrance, pungent；It is cold in nature；Return lung, stomach, the heart, large intestine channel；With surname dissipate wind
Heat, effect of removing summer-heat blood poison；For treating various febrile diseases, such as body heat, dermexanthesis, hair spot, heat toxin sore carbuncle, abscess of throat disease.
The wherein described sophora bud, is the bud of legume Chinese scholartree；Cold nature；Bitter；With cooling blood and hemostasis, clearing liver-fire
Effect；For treat have blood in stool, hemorrhoid blood, bloody flux, uterine bleeding, haematemesis, bleeding from five sense organs or subcutaneous tissue, the hot hot eyes of liver, the disease such as dizziness of having a headache.
The wherein described sterculia seed is sweet, light；It is cool in nature；It is slightly poisonous；Return lung, large intestine channel；With clearing heat and moistening lung, relieving sore-throat solution
Poison, the effect relaxed bowel；For treating lung heat celostomia, dry cough without phlegm, pharyngodynia with dryness, thermojunction is just closed, the disease such as headache and hot eyes.
Above-mentioned a kind of red sage compound tea with hypotensive activity, it is preferred that the red sage root leaf is 35-45 parts, further
It is preferred that, the red sage root leaf is 40 parts.
Above-mentioned a kind of red sage compound tea with hypotensive activity, it is preferred that the ginkgo leaf is 10-15 parts, further
It is preferred that, the ginkgo leaf is 15 parts.,
Above-mentioned a kind of red sage compound tea with hypotensive activity, it is preferred that the folium artemisiae argyi is 3-6 parts, it is further preferred that institute
Folium artemisiae argyi is stated for 5 parts.
Above-mentioned a kind of red sage compound tea with hypotensive activity, it is preferred that the honeysuckle is 2-5 parts, further excellent
Choosing, the honeysuckle is 3 parts.
Above-mentioned a kind of red sage compound tea with hypotensive activity, it is preferred that the sophora bud is 1-3 parts, further preferably
, the sophora bud is 3 parts.
Above-mentioned a kind of red sage compound tea with hypotensive activity, it is preferred that the sterculia seed is 1-3 parts, further excellent
Choosing, the sterculia seed is 2 parts.
Preferably the synergistic function maximum of tea can be made by above-mentioned, blood pressure lowering effect reaches that most preferably, mouthfeel is most
It is good.
A kind of red sage compound tea with hypotensive activity, the tea is made up of a variety of gentle natural materials, each original
Expect medicinal material between have synergistic function, with it is clearing heat and detoxicating, promoting blood circulation and removing obstruction in channels the effects such as, blood pressure lowering effect is notable；And it is nontoxic
Side effect, fragrant in taste, sweetness are suitable as teabag drink and drunk for a long time.
Further, the invention provides a kind of preparation method of the red sage compound tea with hypotensive activity, its is specific
Preparation process is as follows：
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 200-300 DEG C, is dried under 80~90 DEG C of temperature conditionss
To moisture≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 250-350 DEG C, in 85~90 DEG C of temperature conditionss
It is lower to be dried to moisture≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 150-200 DEG C, at 80~85 DEG C
Dried under temperature conditionss to moisture≤5%；New fresh honeysuckle is taken to be dried under 120~145 DEG C of temperature conditionss
Do to moisture≤3%；The fresh sophora bud is taken to be dried under 120~145 DEG C of temperature conditionss to moisture≤3%；
The fresh sterculia seed is taken to be dried under 160~185 DEG C of temperature conditionss to moisture≤5%；
2nd, mixed after above-mentioned raw materials are crushed by proportioning and obtain finished product.
The preparation method of above-mentioned a kind of red sage compound tea with hypotensive activity, wherein to each raw medicinal material in step 1
High-temperature process is carried out, bacterial virus can be killed, it is ensured that the clean hygiene of tea；Can inactivate again biology enzyme and decompose it is poisonous into
Point, it is ensured that the active principle of tea is not decomposed and is lost in, and reduces toxic side effect；Working substance in medicinal material can be concentrated by drying moisture
Matter, improves concentration of active substance, improves the blood pressure lowering effect of tea.
Compared with prior art, beneficial effects of the present invention：
1st, tea of the present invention is made different effective active compositions produce Synergistic and made by the rational compatibility of each raw medicinal material
With greatly exciting the property of medicine of effective active matter, blood pressure lowering effect is more preferable.
2nd, tea of the present invention selects a variety of gentle bulk drugs, is formulated by optimal compatibility, drug effect is gentle, nontoxic secondary work
With.
3rd, tea of the present invention improves the mouthfeel of tea by the collocation of various flavor bulk drug.
4th, tea of the present invention is handled by high-temperature technology, is improved the concentration of active principle, is reduced toxic side effect, carries
The high adaptability of tea.
Embodiment
With reference to test example and embodiment, the present invention is described in further detail.But this should not be understood
Following embodiment is only limitted to for the scope of above-mentioned theme of the invention, it is all that this is belonged to based on the technology that present invention is realized
The scope of invention.
Embodiment 1
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 250 DEG C, is dried to moisture and contained under 85 DEG C of temperature conditionss
Amount≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 300 DEG C, is dried under 88 DEG C of temperature conditionss to moisture
Content≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 180 DEG C, is dried under 83 DEG C of temperature conditionss to moisture
Content≤5%；New fresh honeysuckle is taken to be dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 175 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：40 parts of red sage root leaf, 15 parts of ginkgo leaf, 5 parts of folium artemisiae argyi, 3 parts of honeysuckle, 3 parts of the sophora bud is fat big
2 parts of sea, which is mixed, obtains finished product.
Embodiment 2
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 200 DEG C, is dried to moisture and contained under 90 DEG C of temperature conditionss
Amount≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 250 DEG C, is dried under 85 DEG C of temperature conditionss to moisture
Content≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 200 DEG C, is dried under 80 DEG C of temperature conditionss to moisture
Content≤5%；New fresh honeysuckle is taken to be dried under 145 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 120 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 185 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：35 parts of red sage root leaf, 15 parts of ginkgo leaf, 3 parts of folium artemisiae argyi, 5 parts of honeysuckle, 1 part of the sophora bud is fat big
3 parts of sea, which is mixed, obtains finished product.
Embodiment 3
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 200 DEG C, is dried to moisture and contained under 80 DEG C of temperature conditionss
Amount≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 250 DEG C, is dried under 90 DEG C of temperature conditionss to moisture
Content≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 150 DEG C, is dried under 80 DEG C of temperature conditionss to moisture
Content≤5%；New fresh honeysuckle is taken to be dried under 120 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 120 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 160 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：45 parts of red sage root leaf, 10 parts of ginkgo leaf, 6 parts of folium artemisiae argyi, 2 parts of honeysuckle, 3 parts of the sophora bud is fat big
1 part of sea, which is mixed, obtains finished product.
Embodiment 4
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 300 DEG C, is dried to moisture and contained under 80 DEG C of temperature conditionss
Amount≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 350 DEG C, is dried under 85 DEG C of temperature conditionss to moisture
Content≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 200 DEG C, is dried under 85 DEG C of temperature conditionss to moisture
Content≤5%；New fresh honeysuckle is taken to be dried under 145 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 120 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 160 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：50 parts of red sage root leaf, 5 parts of ginkgo leaf, 2 parts of folium artemisiae argyi, 8 parts of honeysuckle, 5 parts of the sophora bud is fat big
1 part of sea, which is mixed, obtains finished product.
Embodiment 5
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 300 DEG C, is dried to moisture and contained under 90 DEG C of temperature conditionss
Amount≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 350 DEG C, is dried under 90 DEG C of temperature conditionss to moisture
Content≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 150 DEG C, is dried under 80 DEG C of temperature conditionss to moisture
Content≤5%；New fresh honeysuckle is taken to be dried under 145 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 120 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 185 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：30 parts of red sage root leaf, 20 parts of ginkgo leaf, 10 parts of folium artemisiae argyi, 1 part of honeysuckle, 1 part of the sophora bud is fat
5 parts of sea, which is mixed, obtains finished product.
Comparative example 1
Take tender folium artemisiae argyi, after green removing in high temperature at a temperature of 180 DEG C, dried under 83 DEG C of temperature conditionss to moisture≤
5%.
Comparative example 2
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 250 DEG C, is dried to moisture and contained under 85 DEG C of temperature conditionss
Amount≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 300 DEG C, is dried under 88 DEG C of temperature conditionss to moisture
Content≤5%；New fresh honeysuckle is taken to be dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 175 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：40 parts of red sage root leaf, 15 parts of ginkgo leaf, 3 parts of honeysuckle, 3 parts of the sophora bud, 2 parts of the sterculia seed enters
Row mixing obtains finished product.
Comparative example 3
1st, red sage root tender leaf is taken, after green removing in high temperature at a temperature of 250 DEG C, is dried to moisture and contained under 85 DEG C of temperature conditionss
Amount≤5%.
Comparative example 4
1st, ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 300 DEG C, is dried to moisture and contained under 88 DEG C of temperature conditionss
Amount≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 180 DEG C, is dried to moisture and contained under 83 DEG C of temperature conditionss
Amount≤5%；New fresh honeysuckle is taken to be dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sophora bud is taken to exist
Dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to be carried out under 175 DEG C of temperature conditionss
Dry to moisture≤5%；
2nd, pressed after above-mentioned raw materials are crushed：15 parts of ginkgo leaf, 5 parts of folium artemisiae argyi, 3 parts of honeysuckle, 3 parts of the sophora bud, 2 parts of the sterculia seed is mixed
Close and obtain finished product.
Pharmacodynamics and toxicity test：
In order to confirm the efficacy and saferry of tea of the present invention, inventor has carried out pharmacodynamics and toxicity test is investigated.Adopted
Research method and result of the test are as follows：
1st, test objective：Hypotensive activity of the red sage compound tea of the present invention to original hypertensive rat.
2nd, test material
（1）Medicine and reagent：
Tea prepared by embodiment 1-5 steeps the tea in boiling water respectively；
Steeped the tea in boiling water respectively according to the comparative example 1-4 finished products prepared；
（2）Animal：Original hypertensive rat 90 is chosen, body weight is 200~250g；Raise in positive pressure purification ventilation animal
Room, 25 ± 2 DEG C of room temperature, ad lib and drinking-water.
3rd, test method and result
Pre-processed before experiment：Tested rat is put into measuring cell and is trained 2 weeks, and blood pressure is determined the next day second week rises.
Animal is put into 37 ± 1 DEG C of electrocaloric effect and heated before pressure measurement, and determining rat with RBP-1 type rat blood pressures instrument after 15 minutes shrinks
Pressure.
Process of the test：Original hypertensive rat is randomly divided into 9 groups, every group 10.Persistently drunk to rat brewed
Tea, and observe the ingesting of mouse, activity and excretion the situation situation without exception of each group and occur.After 5 weeks, the receipts of rat are determined
Contractive pressure, determines 3 times, averages every time.
Result of the test：
Logging is as follows：（It is that the measurement to original hypertensive rat systolic pressure is counted after being administered 5 weeks shown in table
As a result）
| Group number | Average blood pressure before experiment（mmHg） | Average blood pressure after 5 weeks（mmHg） | Blood pressure decreasing value（mmHg） |
| Embodiment 1 | 158.6 | 134.8 | 23.8 |
| Embodiment 2 | 157.8 | 135.1 | 22.7 |
| Embodiment 3 | 157.3 | 135.0 | 22.3 |
| Embodiment 4 | 158.3 | 135.8 | 22.5 |
| Embodiment 5 | 158.4 | 135.4 | 23.0 |
| Comparative example 1 | 158.9 | 157.8 | 1.1 |
| Comparative example 2 | 157.8 | 140.8 | 17.0 |
| Comparative example 3 | 157.4 | 147.6 | 9.8 |
| Comparative example 4 | 157.2 | 148.5 | 8.7 |
From above-mentioned record result, the tea of embodiment 1-5 preparations is taken after 5 weeks, the blood pressure of rat is significantly reduced, it was demonstrated that
Red sage compound tea blood pressure lowering effect of the present invention is notable；In comparative example 1 and 3, the blood pressure lowering effect of single bulk drug is poor, comparative example 2
With 4 in lack bulk drug simply, the effect of tea hypotensive is significantly reduced, and comparative example 1+2 blood pressure lowering effect is also notable
Less than embodiment 1-5, therefore, there is the effect of Synergistic in red sage compound tea of the present invention between multi-flavor bulk drug, can be significantly
Reduce blood pressure.
Claims (10)
1. a kind of red sage compound tea with hypotensive activity, it is characterised in that be the raw material preparation by following weight
：30-50 parts of red sage root leaf, 5-20 parts of ginkgo leaf, 2-10 parts of folium artemisiae argyi, 1-8 parts of honeysuckle, 1-5 parts of the sophora bud, sterculia seed 1-5
Part.
2. red sage compound tea according to claim 1, it is characterised in that described red sage root leaf is 35-45 parts.
3. red sage compound tea according to claim 1, it is characterised in that described ginkgo leaf is 10-15 parts.
4. red sage compound tea according to claim 1, it is characterised in that described folium artemisiae argyi is 3-6 parts.
5. red sage compound tea according to claim 1, it is characterised in that described honeysuckle is 2-5 parts.
6. red sage compound tea according to claim 1, it is characterised in that the described sophora bud is 1-3 parts.
7. red sage compound tea according to claim 1, it is characterised in that the described sterculia seed is 1-3 parts.
8. red sage compound tea according to claim 1, it is characterised in that the red sage compound tea is matched somebody with somebody by following parts by weight
What the raw material of ratio was prepared from：40 parts of red sage root leaf, 15 parts of ginkgo leaf, 5 parts of folium artemisiae argyi, 3 parts of honeysuckle, 3 parts of the sophora bud, 2 parts of the sterculia seed.
9. red sage compound tea according to claim 1, it is characterised in that described red sage compound tea through the following steps that
Prepare：
（1）Red sage root tender leaf is taken, after green removing in high temperature at a temperature of 200-300 DEG C, is dried under 80~90 DEG C of temperature conditionss
Do to moisture≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 250-350 DEG C, in 85~90 DEG C of temperature strip
Dried under part to moisture≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 150-200 DEG C, at 80~85 DEG C
Temperature conditionss under dried to moisture≤5%；New fresh honeysuckle is taken to be carried out under 120~145 DEG C of temperature conditionss
Dry to moisture≤3%；Take the fresh sophora bud dried under 120~145 DEG C of temperature conditionss to moisture≤
3%；The fresh sterculia seed is taken to be dried under 160~185 DEG C of temperature conditionss to moisture≤5%；
（2）Mixed after above-mentioned raw materials are crushed by proportioning and obtain finished product.
10. red sage compound tea according to claim 9, it is characterised in that described red sage compound tea is by following step
Suddenly prepare：
（1）Red sage root tender leaf is taken, after green removing in high temperature at a temperature of 250 DEG C, is dried under 85 DEG C of temperature conditionss to moisture
Content≤5%；Ginkgo tender leaf is taken, after green removing in high temperature at a temperature of 300 DEG C, is dried under 88 DEG C of temperature conditionss to water
Divide content≤5%；Tender folium artemisiae argyi is taken, after green removing in high temperature at a temperature of 180 DEG C, is dried under 83 DEG C of temperature conditionss to water
Divide content≤5%；New fresh honeysuckle is taken to be dried under 130 DEG C of temperature conditionss to moisture≤3%；Take the fresh sophora bud
Dried under 130 DEG C of temperature conditionss to moisture≤3%；The fresh sterculia seed is taken to enter under 175 DEG C of temperature conditionss
Row is dried to moisture≤5%；
（2）Mixed after above-mentioned raw materials are crushed by proportioning and obtain finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710256362.0A CN107019724A (en) | 2017-04-19 | 2017-04-19 | A kind of red sage compound tea with hypotensive activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710256362.0A CN107019724A (en) | 2017-04-19 | 2017-04-19 | A kind of red sage compound tea with hypotensive activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107019724A true CN107019724A (en) | 2017-08-08 |
Family
ID=59526973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710256362.0A Pending CN107019724A (en) | 2017-04-19 | 2017-04-19 | A kind of red sage compound tea with hypotensive activity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107019724A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509619A (en) * | 2002-12-20 | 2004-07-07 | 四川简阳翠屏湖生态资源开发有限公司 | Red rooted salvia |
| CN101129515A (en) * | 2007-09-16 | 2008-02-27 | 牛兴民 | Method of preparing tea for lowering blood pressure and lowering blood fat |
-
2017
- 2017-04-19 CN CN201710256362.0A patent/CN107019724A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509619A (en) * | 2002-12-20 | 2004-07-07 | 四川简阳翠屏湖生态资源开发有限公司 | Red rooted salvia |
| CN101129515A (en) * | 2007-09-16 | 2008-02-27 | 牛兴民 | Method of preparing tea for lowering blood pressure and lowering blood fat |
Non-Patent Citations (3)
| Title |
|---|
| 刘丽莉等: "丹参叶绿叶的保质干燥技术研究", 《干燥技术与设备》 * |
| 曾晓虎: "《中西汇通中药手册》", 31 May 2016, 人民军医出版社 * |
| 江滨等: "《汉英临床中药药典》", 31 January 2013, 安徽科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (en) | Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof | |
| CN105112265A (en) | Health-care fig wine and preparation method thereof | |
| CN102894437A (en) | Honeysuckle-lotus plumule beverage with functions of heat clearing and pathogenic fire reducing, and preparation method thereof | |
| KR102127706B1 (en) | Preparation for improving blood circulation comprising mixed oriental medicinal extracts | |
| CN101085962A (en) | Wine of bamboo and cogongrass | |
| KR101513240B1 (en) | A composition comprising extracts of herbal mixture for fatigue recovery as in gradient compounds | |
| KR102452902B1 (en) | Herbal medicinal liquor and its manufacturing method | |
| CN107019724A (en) | A kind of red sage compound tea with hypotensive activity | |
| KR101476092B1 (en) | Beverage for relieving hangover and manufacturing method thereof | |
| CN107019725A (en) | A kind of red sage compound tea with effect for reducing blood fat | |
| CN106306959A (en) | Technology for preparing beverage containing honeysuckle extract | |
| CN106889273A (en) | A kind of root of herbaceous peony tea with effect for reducing blood fat | |
| CN1105213A (en) | Canned liquorice-wheat-jujube soup | |
| KR20200061285A (en) | Food Composition for blood circulation and for Preventing blood vessel disease Comprising Extract of Galangal | |
| KR100377813B1 (en) | New bamboo extract-containing composition for treatment, and agents comprising the same | |
| KR20030079289A (en) | The carbonated soft drinks a manufacturing process and a composition of ling indigestion hangover cures. | |
| KR102203094B1 (en) | Composition for preventing and improving menstrual pain and skin troubles | |
| CN106974040A (en) | A kind of root of herbaceous peony tea with hypotensive activity | |
| CN107318971A (en) | A kind of preparation method of fruit antistaling agent | |
| KR101866915B1 (en) | Manufacturing method for extracts granule of oriental herb medicine materials for improving constipation and extracts granule manufactured by the same | |
| CN107029024A (en) | A kind of paniculate swallowwort tea acted on wind-damp dispelling | |
| CN107853533A (en) | A kind of clearing heat and expelling damp health drink and preparation method thereof | |
| KR102127726B1 (en) | Preparation for improving blood circulation comprising mixed oriental medicinal extracts | |
| CN107027932A (en) | It is a kind of that there is the red sage compound tea for improving chronic gastritis effect | |
| CN108719542A (en) | A kind of ginkgo compound tea suitable for diabetes patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170808 |
|
| RJ01 | Rejection of invention patent application after publication |